Evidence map›Paper›PMID 37440612›Full record

ArticleScience (New York, N.Y.)2023

RHINO directs MMEJ to repair DNA breaks in mitosis.

Alessandra Brambati, Olivia Sacco, Sarina Porcella, Joshua Heyza, Mike Kareh, Jens C Schmidt, Agnel Sfeir

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 124 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Dual Inhibition of TRIP13 and Aurora A Induces Mitotic DNA Damage and Concurrent Pyroptotic-Apoptotic Cell Death in Rb-Deficient Cancer Cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. HPV16 E6 oncoprotein promotes microhomology-mediated viral integration by increasing PolΘ protein expression.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  19. Article
  20. Telomere Crisis Shapes Cancer Evolution.Cold Spring Harbor perspectives in biology · 2026
    Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alessandra Brambati *Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-3816-425X
Olivia Sacco *Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0009-0002-7143-8870
Sarina Porcella *Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-1926-2532
Joshua HeyzaInstitute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, MI, USA.ORCID 0000-0003-0847-0501
Mike KarehMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jens C SchmidtInstitute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, MI, USA.ORCID 0000-0001-9061-7853
Agnel SfeirMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-1633-8535
Memorial Sloan Kettering Cancer Center · USMichigan State University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
POLQ Synthetic Lethality in HR-Deficient Pancreatic AdenocarcinomaR01CA245005 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SFEIR, AGNEL, SIMEONE, DIANE M · 2020 to 2024
$3.2M
Telomere-independent strategies to protect chromosome endsDP2CA195767 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SFEIR, AGNEL · 2014 to 2014
$2.5M
Single-molecule Analysis of the DNA Damage Response in Living CellsDP2GM142307 · NIGMS · MICHIGAN STATE UNIVERSITY · PI SCHMIDT, JENS CHRISTOPHER · 2020 to 2020
$2.1M
Investigating PolQ-mediated alternative NHEJ in breast cancerR01CA229161 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SFEIR, AGNEL · 2019 to 2023
$2.1M
Defining the mechanism of Shieldin complex in DNA end joiningF32GM139292 · NIGMS · MICHIGAN STATE UNIVERSITY · PI HEYZA, JOSHUA · 2020 to 2022
$201k
NCI NIH HHS DP2 CA195767NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA229161NCI NIH HHS R01 CA245005NIGMS NIH HHS DP2 GM142307NIGMS NIH HHS F32 GM139292
6 · The paper itself

Abstract

Nonhomologous end-joining (NHEJ) and homologous recombination (HR) are the primary pathways for repairing DNA double-strand breaks (DSBs) during interphase, whereas microhomology-mediated end-joining (MMEJ) has been regarded as a backup mechanism. Through CRISPR-Cas9-based synthetic lethal screens in cancer cells, we identified subunits of the 9-1-1 complex (RAD9A-RAD1-HUS1) and its interacting partner, RHINO, as crucial MMEJ factors. We uncovered an unexpected function for RHINO in restricting MMEJ to mitosis. RHINO accumulates in M phase, undergoes Polo-like kinase 1 (PLK1) phosphorylation, and interacts with polymerase θ (Polθ), enabling its recruitment to DSBs for subsequent repair. Additionally, we provide evidence that MMEJ activity in mitosis repairs persistent DSBs that originate in S phase. Our findings offer insights into the synthetic lethal relationship between the genes

Indexed as

Cell Cycle ProteinsDNA Breaks, Double-StrandedDNA End-Joining RepairExonucleasesMitosisCarrier ProteinsHEK293 CellsHumansPoly(ADP-ribose) PolymerasesCarrier ProteinsCell Cycle ProteinsExonucleasesHUS1 protein, humanPoly(ADP-ribose) PolymerasesRad1 protein, humanrad9 proteinRHNO1 protein, human

Identifiers

PMID37440612
PMCPMC10561558
OpenAlexW4384154872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.